News
ASCO 2024: An Expert’s Top Hematology Highlights
Chief science officer at American Cancer Society pinpoints practice-changing blood cancer research that emerged at this year’s conference.
News
In Prostate Cancer, Most Roads Lead to VA Pathway
The newly updated US Department of Veterans Affairs (VA) prostate cancer clinical pathway...
News
Neck Pain in Migraine Is Common, Linked to More Disability
More than two-thirds report the condition, which ‘is probably worth asking about.’
News
Stroke Recurrence Risk Doubles in Patients With AF Who Stop Anticoagulation Therapy
Over a mean 2.9 years, 13.4% of those who discontinued the drugs had another ischemic attack.
Article
AVAHO Mtg: Germline Testing Key for Vets With High-Risk PC
Attendees learn that about 10% of patients could benefit from testing
News
CMS Announces End to Cyberattack Relief Program
Payments from the Accelerated and Advance Payment program will close for application in July.
News
Beta Thalassemia: Pricey Gene Therapy Hits The Mark
A landmark new treatment for bleeding disorder banishes the need for transfusions, but it’s exorbitantly expensive.
News
Myeloma: VRd Plus Isatuximab Improves Outcomes
Newly diagnosed, transplant-ineligible patients with multiple myeloma fare better when standard treatment gets a boost.
News
MCL: Dual Therapy ‘Promising’ in Patients With TP53 mutations
Outcomes improved across cohorts when venetoclax was added to ibrutinib, new analysis of phase-3 study finds.
News
CAR T for B-ALL: Game Changer For Young Patients?
Survival rises as tisagenlecleucel therapy reaches those with less severe disease, displacing HSCT.
News
New Drug Combo Boosts PFS
Patients with Hodgkin lymphoma fared better on a less toxic alternative to gold-standard BrECADD therapy.
News
In HPV-Positive Head and Neck Cancer, Treatment Is a Quandary
These patients have better outcomes, but less intense therapy isn’t yet proven.
News
Head and Neck Cancer in Spotlight at AVAHO Regional Meeting
AVAHO held a regional meeting in Seattle on May 4, 2024, that was entirely devoted to head and neck cancer.
News
Global Quest to Cut CAR T Costs
Reducing the high price of CAR T-cell therapy is a top priority worldwide, with new efforts underway in Asia and South America.
News
New Trial Deepens Debate Over Late-Preterm Steroids
The early cancellation of a trial in southern India suggests that the use of antenatal steroids to prevent respiratory complications after late-...